Recent Publications on : |  |
| Analysis of BRCA1 and BRCA2 Mutations in Southern Iranian Breast Cancer Patients.
| 3rd November, 2009
| Shiraz Institute for Cancer Research, Shiraz University of Medical
|
| Breast cancer immunohistochemical features in young women with BRCA 1/2 mutations.
| 3rd November, 2009
| Kyiv City
|
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
Integrins containing the beta(3) subunit are key players in tumor growth...
Direct Link | 31st October, 2009
| IHCC (International Hereditary Cancer Centre), Department of Genetics and
|
Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase.
The breast and ovarian cancer suppressor protein BRCA2 controls the RAD51...
Direct Link | 31st October, 2009
| The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research
|
Cancer genetics and reproduction.
Cancers of the reproductive organs (i.e., ovaries, uterus and testes),...
Direct Link | 30th October, 2009
| Institute of Cancer Research, 15 Cotswold Road, Sutton, SM2 5NG, UK.
|
The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
In an ethnically-homogeneous population, it is valuable to identify...
Direct Link | 30th October, 2009
| Epidemiology Research Unit, Research Centre, Centre hospitalier de
|
PIK3CA in Breast Carcinoma: A Mutational Analysis of Sporadic and Hereditary Cases.
The PI3K-Akt cascade is a key signaling pathway involved in cell...
Direct Link | 29th October, 2009
| *Division of Surgical, Molecular and Ultrastructural Pathology, Department
|
Fanconi Anemia Complementation Group FANCD2 Protein Serine 331 Phosphorylation Is Important for Fanconi Anemia Pathway Function and BRCA2 Interaction.
Fanconi anemia is a cancer-prone inherited bone marrow failure and cancer...
Direct Link | 29th October, 2009
| Department of Microbiology, University of Virginia Health System,
|
Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes.
The somatic fusion of TMPRSS2 to ETS oncogenes is a common event in...
Direct Link | 29th October, 2009
| 1Institute of Human Genetics, University Hospital Ulm; 2Urologic
|
[Serous genital carcinoma : Molecular pathogenesis and the role of tubal fimbria.]
Serous carcinomas develop at various sites of the Mullerian system, in...
Direct Link | 28th October, 2009
| Institut fur Pathologie, Landeskrankenhaus Graz West, Gostingerstr. 22,
|
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PURPOSE: To estimate the risk for contralateral breast cancer in members...
Direct Link | 28th October, 2009
| Center of Familial Breast and Ovarian Cancer, Department of Gynecology and
|
Contralateral Breast Cancer in BRCA1/BRCA2 Mutation Carriers: The Story of the Other Side.
PURPOSE: To estimate the risk for contralateral breast cancer in members...
Direct Link | 28th October, 2009
| Dana Farber Cancer Institute; Brigham and Women's Hospital, Boston, MA.
|
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
Mutations in DNA mismatch repair genes underlie lynch syndrome (HNPCC)....
Direct Link | 24th October, 2009
| Sharret Institute of Oncology, Hadassah-Hebrew University Medical Center,
|
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Juvenile breast cancer is rare and poorly known. We studied a series of...
Direct Link | 24th October, 2009
| Unit of Molecular Pathology and Genomics, Aging Research Center (CeSI) G.
|
Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
Recently, the SNPs rs11614913 in hsa-mir-196a2 and rs3746444 in...
Direct Link | 23rd October, 2009
| IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
|
